Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.
Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.3%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check57 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check64 days agoChange DetectedSeveral links related to rare diseases and medical resources have been removed, including those for renal cell carcinoma and Cabozantinib.SummaryDifference0.6%
- Check71 days agoChange DetectedThe website has been updated to version 2.12.2, adding numerous resources related to rare diseases, including links to PubMed articles and treatment information for renal cell carcinoma, while removing the previous version 2.12.1.SummaryDifference5%
Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.